MedCity News October 24, 2019
The partnership will have a particular focus on therapies to treat sickle cell disease and HIV, with each party committing $100 million to the effort.
Although touted as having potential to cure some of the most intractable of human illnesses, gene therapies also carry some eye-popping price tags that have threatened to limit their availability to wealthy countries. However, a new public-private partnership aims to make them available to people around the world, including in developing countries.
The National Institutes and Health and the Bill & Melinda Gates Foundation plan to each invest $100 million in an effort to develop affordable gene therapies to treat sickle cell disease and HIV and make them available around the world, including in low-resource...
Today's Sponsors
Today's Sponsor